Surprise Me!

Can Valeant deliver Salix savings? | Lex

2019-03-08 1 Dailymotion

► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs<br /><br />Valeant has agreed to buy Salix, the gastrointestinal specialist, for $14.5bn. Lex's Oliver Ralph and Robert Armstrong discuss whether the serial pharmaceuticals dealmaker's cost-cutting plans are achievable and whether its strategy is sustainable.<br /><br />► Lex: http://bit.ly/1I14JZF<br /><br />► FT Business: http://bit.ly/1KUK08s<br /><br />Make better investment decisions with Lex<br />http://www.ft.com/lex<br /><br />Click here for more Lex videos<br />http://video.ft.com/Lex<br /><br />For more video content from the Financial Times, visit http://www.FT.com/video<br /><br />Twitter https://twitter.com/ftvideo<br />Facebook https://www.facebook.com/financialtimes

Buy Now on CodeCanyon